Form 4: Equifax CEO Mark Begor Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Equifax CEO Mark Begor exercised stock options and sold shares of common stock on April 26, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- On April 26, 2024, Mark W Begor, CEO of Equifax Inc., executed stock options to acquire 58,300 shares of common stock.
- These options were exercised at prices of $127.37 and $138.45 per share.
- Concurrently, Begor sold a total of 58,300 shares of Equifax common stock in multiple transactions.
- The sales occurred at weighted average prices of $227.0609, $225.8809, and $225.0796.
- The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 6, 2023.
- Following these transactions, Begor directly owns 109,220 shares of Equifax common stock.
- Begor also indirectly owns shares through various grantor retained annuity trusts (GRATs).
- These GRATs include the 2-Year 2023 GRAT (69,360 shares), 2-year Feb 2024 GRAT (20,025 shares), 2-year May 2022 GRAT (13,475 shares), and 4-Year 2021 GRAT (23,083 shares).
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports transactions executed under a pre-existing plan. It doesn't inherently indicate positive or negative sentiment about the company's future prospects.
Industry Context
Insider transactions are common, and the use of 10b5-1 plans allows corporate executives to sell shares in a pre-planned manner to avoid accusations of trading on inside information. The market will likely view this as a routine transaction.
Comparison to Industry Standards
- It's common for CEOs of publicly traded companies, including those in the financial services sector like Equifax, to have stock option grants as part of their compensation packages.
- Companies like Experian and TransUnion, which are Equifax's main competitors, also utilize stock options and equity-based compensation for their executives.
- The use of 10b5-1 trading plans is a standard practice among executives to manage their stock sales in compliance with insider trading regulations.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the sales mitigates concerns about insider information being used.
- Employees are unlikely to be directly affected by these transactions.
Key Dates
| Date | Description |
|---|---|
| 11/6/2023 | Date the reporting person adopted the rule 10b5-1 trading plan |
| 02/22/2022 | Date exercisable for stock options |
| 02/22/2025 | Expiration date for stock options |
| 04/26/2024 | Date of transaction (exercise of stock options and sale of shares) |
| 04/30/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.